Digital PET/CT with 18F-FACBC in early castration-resistant prostate cancer: our preliminary results
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Medical Devices"
DOI: 10.1080/17434440.2022.2117612
Abstract: ABSTRACT Background We assessed the role of digital PET/CT (dPET/CT) with 18F-FACBC in patients affected by castration-resistant prostate cancer with PSA levels ≤ 3 ng/mL (early CRPC), no lesions detectable at cross-sectional imaging (CIM) and… read more here.
Keywords: dpet; digital pet; prostate cancer; 18f facbc ... See more keywords
Detection Rate and Clinical Impact of PET/CT with 18F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10010177
Abstract: Our aim was to assess the detection rate (DR) of positron emission computed tomography (PET/CT) with anti-1-amino-3-[18F]-flurocyclobutane-1-carboxylic acid (18F-FACBC) in patients with biochemical recurrence (BCR) from prostate cancer (PC). As a secondary endpoint, we evaluated… read more here.
Keywords: recurrence; 18f facbc; prostate; detection rate ... See more keywords